-
Astronomers have unleashed a powerful new AI tool called RAVEN to comb through data from NASA’s TESS mission—and it’s paying off in a big way. By analyzing millions of stars, the system has confirmed over 100 exoplanets, including 31 brand-new worlds, and identified thousands more promising candidates. What makes this especially exciting is the discovery of rare and extreme planets, like those that whip around their stars in less than a day and others lurking in the mysterious “Neptunian desert,” where planets are thought to be scarce.
-
GLP-1 drugs like semaglutide—best known for treating diabetes and driving weight loss under the brand names Ozempic and Wegovy—may also deliver a surprising mental health boost. In a massive study tracking nearly 100,000 people over more than a decade, researchers found that these medications were linked to significantly fewer psychiatric hospital visits and sick days.
-
A new analysis of the “Boltzmann brain” paradox suggests our memories and sense of reality could, in theory, be random illusions born from cosmic chaos. By uncovering circular reasoning in how physicists think about time and entropy, the study raises fresh doubts about what we can truly know about the past.
-
Physicists are rethinking one of quantum mechanics’ biggest puzzles: how fuzzy possibilities become definite reality. New research suggests that spontaneous “collapse” processes—possibly linked to gravity—could subtly blur time itself. This wouldn’t affect clocks we use today, but it reveals a hidden limit to how precise time can ever be. The findings open a new path toward uniting quantum physics with gravity.
-
Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually help patients in any meaningful way, according to a major review of over 20,000 participants. Even more concerning, they may increase the risk of brain swelling and bleeding, sometimes without obvious symptoms.
